Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
Chanaki Amaratunga is a Sri Lankan scientist who joined the Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand in 2019 to coordinate the Development of Triple Artemisinin Combination Therapies (DeTACT) project. This is in line with her research interest of working on bench-to-bedside strategies for treating drug resistant malaria in low- and middle-income countries.
Chanaki obtained her PhD from the University of Colombo, Sri Lanka, working on the vaccinology and immunology of malaria. She did post-doctoral research on molecular biology and protein chemistry of malaria at the International Center of Genetic Engineering and Biotechnology, New Delhi, India.
Chanaki further trained at the Laboratory of Malaria and Vector Research (LMVR) at the National Institutes of Health (NIH), USA, where she worked on laboratory and Cambodia-based clinical studies of drug resistant malaria for over ten years and also served as the International Scientific Program Manager for LMVR/NIH.